US Bancorp’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,924
| Closed | -$334K | – | 4150 |
|
|
2023
Q2 | $334K | Sell |
7,924
-33,745
| -81% | -$1.36M | ﹤0.01% | 1614 |
|
|
2023
Q1 | $1.48M | Buy |
41,669
+13,654
| +49% | +$495K | ﹤0.01% | 916 |
|
|
2022
Q4 | $1.03M | Sell |
28,015
-366
| -1% | -$14.5K | ﹤0.01% | 1053 |
|
|
2022
Q3 | $1.34M | Sell |
28,381
-96
| -0.3% | -$6.2K | ﹤0.01% | 934 |
|
|
2022
Q2 | $2.04M | Buy |
28,477
+1,932
| +7% | +$141K | ﹤0.01% | 808 |
|
|
2022
Q1 | $2.15M | Sell |
26,545
-1,075
| -4% | -$90.9K | ﹤0.01% | 859 |
|
|
2021
Q4 | $2.84M | Sell |
27,620
-629
| -2% | -$60.4K | ﹤0.01% | 782 |
|
|
2021
Q3 | $2.47M | Sell |
28,249
-909
| -3% | -$82.3K | ﹤0.01% | 797 |
|
|
2021
Q2 | $2.61M | Buy |
29,158
+672
| +2% | +$56.8K | ﹤0.01% | 787 |
|
|
2021
Q1 | $2.16M | Sell |
28,486
-799
| -3% | -$60.2K | ﹤0.01% | 824 |
|
|
2020
Q4 | $2M | Buy |
29,285
+3
| +0% | +$187 | ﹤0.01% | 814 |
|
|
2020
Q3 | $1.55M | Sell |
29,282
-3,867
| -12% | -$230K | ﹤0.01% | 819 |
|
|
2020
Q2 | $1.93M | Sell |
33,149
-2,276
| -6% | -$122K | 0.01% | 728 |
|
|
2020
Q1 | $1.4M | Buy |
35,425
+1,513
| +4% | +$88.5K | ﹤0.01% | 780 |
|
|
2019
Q4 | $2.02M | Sell |
33,912
-881
| -3% | -$47.4K | 0.01% | 767 |
|
|
2019
Q3 | $1.85M | Buy |
34,793
+485
| +1% | +$24.9K | 0.01% | 789 |
|
|
2019
Q2 | $1.75M | Sell |
34,308
-4,542
| -12% | -$211K | ﹤0.01% | 836 |
|
|
2019
Q1 | $2.01M | Buy |
38,850
+246
| +0.6% | +$11.9K | 0.01% | 769 |
|
|
2018
Q4 | $1.52M | Buy |
38,604
+15,523
| +67% | +$721K | ﹤0.01% | 830 |
|
|
2018
Q3 | $1.19M | Buy |
23,081
+678
| +3% | +$33.2K | ﹤0.01% | 1022 |
|
|
2018
Q2 | $1.05M | Buy |
22,403
+5,414
| +32% | +$224K | ﹤0.01% | 1078 |
|
|
2018
Q1 | $603K | Buy |
16,989
+16,656
| +5,002% | +$652K | ﹤0.01% | 1355 |
|
|
2017
Q4 | $14K | Buy |
+333
| New | +$15.6K | ﹤0.01% | 3043 |
|
|
2017
Q2 | – | Sell |
-709
| Closed | -$32K | – | 3631 |
|
|
2017
Q1 | $32K | Buy |
709
+106
| +18% | +$5.27K | ﹤0.01% | 2692 |
|
|
2016
Q4 | $32K | Buy |
603
+403
| +202% | +$19.5K | ﹤0.01% | 2671 |
|
|
2016
Q3 | $9K | Hold |
200
| – | – | ﹤0.01% | 3035 |
|
|
2016
Q2 | $8K | Sell |
200
-623
| -76% | -$27.4K | ﹤0.01% | 3065 |
|
|
2016
Q1 | $34K | Sell |
823
-194
| -19% | -$8K | ﹤0.01% | 2556 |
|
|
2015
Q4 | $49K | Sell |
1,017
-4,011
| -80% | -$178K | ﹤0.01% | 2463 |
|
|
2015
Q3 | $201K | Buy |
5,028
+755
| +18% | +$33K | ﹤0.01% | 1733 |
|
|
2015
Q2 | $172K | Buy |
+4,273
| New | +$147K | ﹤0.01% | 1845 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
US Bancorp's SYNH Position: Q3 2023 in Review
US Bancorp sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 7,924 shares — an estimated $334K sold.
US Bancorp first reported a position in SYNH in Q2 2015 and held it in 31 quarters. The position peaked at $2.84M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- US Bancorp reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- US Bancorp sold 7,924 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $334K.
- US Bancorp first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 31 quarters.
- US Bancorp's Syneos Health, Inc. Class A Common Stock position peaked at $2.84M in Q4 2021.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on US Bancorp's 13F filing for Q3 2023, filed 3 Nov 2023.